LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 21.74 | 5546 | 5768 | 0.9614 | 0.9902 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 21.74 | 100 | 5768 | 0.0173 | 0.2087 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 21.74 | 7613 | 5768 | 1.3197 | 1.0701 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.45 | 21.74 | 4375 | 6023 | 0.7263 | 0.9227 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.45 | 21.74 | 5957 | 6023 | 0.9890 | 0.9973 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.45 | 21.74 | 87 | 6023 | 0.0144 | 0.1864 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.45 | 21.74 | 8198 | 6023 | 1.3610 | 1.0774 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.42 | 21.74 | 3567 | 6125 | 0.5823 | 0.8714 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.42 | 21.74 | 6350 | 6125 | 1.0367 | 1.0089 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.42 | 21.74 | 70 | 6125 | 0.0114 | 0.1545 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 59.42 | 21.74 | 8780 | 6125 | 1.4334 | 1.0905 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.39 | 21.74 | 3253 | 6112 | 0.5322 | 0.8508 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.39 | 21.74 | 6829 | 6112 | 1.1172 | 1.0274 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.39 | 21.74 | 93 | 6112 | 0.0152 | 0.1956 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 62.39 | 21.74 | 9249 | 6112 | 1.5131 | 1.1044 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.36 | 21.74 | 2763 | 6191 | 0.4463 | 0.8116 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.36 | 21.74 | 7218 | 6191 | 1.1659 | 1.0380 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.36 | 21.74 | 39 | 6191 | 0.0063 | 0.0743 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 64.36 | 21.74 | 9602 | 6191 | 1.5510 | 1.1106 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.33 | 21.74 | 2447 | 6235 | 0.3924 | 0.7835 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.33 | 21.74 | 7689 | 6235 | 1.2331 | 1.0520 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.33 | 21.74 | 37 | 6235 | 0.0059 | 0.0673 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 66.33 | 21.74 | 9949 | 6235 | 1.5955 | 1.1178 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.30 | 21.74 | 1920 | 6244 | 0.3075 | 0.7310 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 68.30 | 21.74 | 8019 | 6244 | 1.2841 | 1.0622 | MN20160310_N01 | D09 |